Labopharm Inc.
Quick facts
Marketed products
- Tramadol HCl · Pain Management
Tramadol is a synthetic opioid analgesic that binds to mu opioid receptors and also inhibits the reuptake of norepinephrine and serotonin to provide pain relief. - Trazodone HCl · Psychiatry / Neurology
Trazodone HCl is a serotonin antagonist and reuptake inhibitor (SARI) that blocks serotonin reuptake and antagonizes serotonin 2A receptors to elevate serotonin levels in the brain. - Ultracet® · Pain Management
Ultracet combines tramadol (an opioid agonist and monoamine reuptake inhibitor) with acetaminophen to provide enhanced pain relief through dual analgesic pathways. - Zaldiar® · Pain Management
Zaldiar combines tramadol (an opioid agonist and monoamine reuptake inhibitor) with paracetamol (acetaminophen) to provide analgesia through dual pathways.
Phase 3 pipeline
- Tramadol HCl Contramid® Once A Day · Pain management
Tramadol HCl is a centrally acting opioid analgesic that works by binding to mu-opioid receptors in the brain. - Tramadol HCl Twice a day · Pain management
Tramadol HCl is a centrally acting opioid analgesic that works by binding to opioid receptors in the brain and spinal cord, reducing pain perception. - Tramadol OAD · Pain Management
Tramadol is an opioid analgesic that binds to mu opioid receptors and also inhibits the reuptake of norepinephrine and serotonin to provide pain relief. - Tramadol Once A Day · Pain management
Tramadol is a centrally acting opioid analgesic that works by binding to opioid receptors in the brain and spinal cord.
Phase 1 pipeline
- Tramadol Contramid OAD
- Zytram · Other
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: